US4248872AExpiredUtility

Method for the treatment of anxiety

42
Individually held — no corporate assignee on recordPriority: Sep 1, 1978Filed: Aug 24, 1979Granted: Feb 3, 1981
Est. expirySep 1, 1998(expired)· nominal 20-yr term from priority
Inventors:David F. Horrobin
A61K 31/415A61K 31/505
42
PatentIndex Score
3
Cited by
0
References
3
Claims

Abstract

A method for the treatment of anxiety which consists of administering dipyridamole or imidazole or a derivative thereof. It has been found that known anti-anxiety agents appear to act as competitive antagonists of thromboxane A2 (TXA2), and it is therefore believed that dipyridamole and imidazole, which inhibit the formation of TXA2, will be effective in the treatment of anxiety.

Claims

exact text as granted — not AI-modified
I claim: 
     
       1. A method for the treatment of anxiety in a subject having an anxiety which method comprises administering to said subject an amount of dipyridamole effective to control said anxiety. 
     
     
       2. A method according to claim 1 wherein said dipyridamole is administered in a daily dosage of from 25 to 1000 mg. 
     
     
       3. A method according to claim 1 wherein said dipyridamole is administered in 4 doses per day of about 12.5 mg of dipyridamole.

Join the waitlist — get patent alerts

Track US4248872A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.